-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Haemonetics, Raises Price Target to $96

Benzinga·08/06/2026 18:25:41
Listen to the news
BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $84 to $96.